
Croissance Drugs Private Limited
Founded in 2014 and headquartered in Maharashtra, India.
Founded in 2014 and headquartered in Maharashtra, India.
Nagpur, Maharashtra, India
+91-XXXXXXXXXX
U24100MH2014PTC252512
252512
Private Limited Indian Non-Government Company
28 Jan 2014
-
-
Unlisted
Roc Mumbai
Name | Designation | Appointment Date | Status |
---|---|---|---|
Meenakshi Shinde ![]() | Director | 28-Jan-2014 | Current |
Chaitali Wankhede ![]() | Director | 09-Oct-2015 | Current |
Chanderlal Jhambia ![]() | Director | 28-Oct-2015 | Current |
Vishal Jhambia ![]() | Director | 28-Oct-2015 | Current |
Enhance accessibility to Croissance Drugs's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
Unlock access to Croissance Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Croissance Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Croissance Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Croissance Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Chanderlal Diwanmal Jhambia was appointed as a Director was appointed as a Director on 28 Oct 2015 & has been associated with this company since 9 years 6 months .
Vishal Chanderlal Jhambia was appointed as a Director was appointed as a Director on 28 Oct 2015 & has been associated with this company since 9 years 6 months .
Chaitali Gantgadhar Wankhede was appointed as a Director was appointed as a Director on 09 Oct 2015 & has been associated with this company since 9 years 7 months .
Meenakshi Ajay Shinde was appointed as a Director was appointed as a Director on 28 Jan 2014 & has been associated with this company since 11 years 3 months .
Croissance Drugs Private Limited was registered on 28 Jan 2014 with Roc Mumbai & aged 11 years 3 months as per MCA records.
Croissance Drugs Private Limited was incorporated on 28 Jan 2014.
The authorized share capital of Croissance Drugs Private Limited is ₹ 0.50 M and paid-up capital is ₹ 0.15 M.
Currently 4 directors are associated with Croissance Drugs Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Croissance Drugs Private Limited is Shop No 4 Second Floor B R Complex Tawakkal Layout, Wadi India, Nagpur, Maharashtra, 440023.
The corporate identification number (CIN) of Croissance Drugs Private Limited is U24100MH2014PTC252512 and the company number is 252512 as per Ministry of Corporate Affairs (MCA).
Search company & director profiles for free and gain access to critical business data.
PB
AB
VM